Acute neurovascular unit protective action of pinocembrin against permanent cerebral ischemia in rats

Journal of Asian Natural Products Research

Volumn 10, Issue 6, 2008, Pages 551-558

  Gao, Mei ^a   Liu, Rui ^a   Zhu, Shen Yin ^a,b   Du, Guan Hua ^a  

^a INSTITUTE OF MATERIA MEDICA   (China)

^b CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Blood brain barrier; Cerebral ischemia; Neurovascular unit; Pinocembrin

Indexed keywords

EVANS BLUE; NORPHENAZONE; PINOCEMBRINE; TRIPHENYLTETRAZOLIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN BLOOD FLOW; BRAIN EDEMA; BRAIN ISCHEMIA; BRAIN PROTECTION; BRAIN SLICE; CEREBROSPINAL FLUID FISTULA; CONTROLLED STUDY; DRUG DOSE COMPARISON; FLUORESCENCE MICROSCOPY; HISTOPATHOLOGY; MALE; NEUROPROTECTION; NONHUMAN; PATHOPHYSIOLOGY; RAT;

ANIMALS; BRAIN EDEMA; BRAIN ISCHEMIA; CEREBROVASCULAR CIRCULATION; EVANS BLUE; FLAVANONES; FLUORESCEIN; MALE; NEUROLOGIC EXAMINATION; NEUROPROTECTIVE AGENTS; OXYGEN; RATS; RATS, SPRAGUE-DAWLEY;

RATTUS;

EID: 45849087303     PISSN: 10286020     EISSN: 14772213     Source Type: Journal    
DOI: 10.1080/10286020801966955     Document Type: Article

References (24)

1. E.H. Lo, T. Dalkara, and M.A. Moskowitz, Nat. Rev. Neurosci. 4, 399 (2003).
2. E.J. Lee, Y.C. Hung, and M.Y. Lee, J. Neurosurg. 91, 1013 (1999).
3. R.M. Dijkhuizen, M. Asahi, and O. Wu, Stroke 33, 2100 (2002).
4. K. Benchenane, V. Berezowski, and M. Fernandez-Monreal, Stroke 36, 1065 (2005).
5. B.V. Zlokovic, Trends Neurosci. 28, 202 (2005).
6. L. Belayev, R. Busto, W. Zhao, and M.D. Ginsberg, Brain Res. 739, 88 (1996).
7. S. Albayrak, Q. Zhao, B.K. Siesjo, and M.L. Smith, Acta Neuropathol. 94, 158 (1997).
8. Z.G. Huang, D. Xue, and E. Preston, Can. J. NeuroSci. 26, 298 (1999).
9. H.S. Han and K. Suk, Curr. Neurovasc. Res. 2, 409 (2005).
10. O.Y. Gursory, A. Can, and T. Dalkara, Stroke 35, 1449 (2004).
11. G.J. Del-Zoppo and N. Engl, J. Med. 354, 553 (2006).
12. V.S. Bankova, S.S. Popov, and N.L. Marekov, J. Chromatogr. 242, 135 (1982).
13. S. Pepeljnjak, I. Jalsenjak, and D. Maysinger, Pharmazie 40, 122 (1985).
14. C.M. Del Rayo, B. Sanchez, H. Quiroz, J.L. Contreras, and R. Mata, J. Ethnopharmacol. 31, 383 (1991).
15. A.C. Santos, S.A. Uyemura, J.L. Lopes, J.N. Bazon, F.E. Mingatto, and C. Curti, Free Radic. Biol. Med. 24, 1455 (1998).
16. S. Sola, R.E. Castro, P.A. Laires, C.J. Steer, and C.M. Rodrigues, Mol. Med. 9, 226 (2003).
17. X.M. Zhu, L.H. Fang, Y.J. Li, and G.H. Du, Vascul. Pharmacol. 46, 160 (2007).
18. H.M. Guang and G.H. Du, Eur. J. Pharmacol. 542, 77 (2006).
19. K. Abe, S. Yuki, and K. Kogure, Stroke 19, 480 (1988).
20. Q. Li and D. Stephenson, Exp. Neurol. 177, 531 (2002).
21. E.L. Zea Longa, P.R. Weinstein, S. Carlson, and R. Cummins, Stroke 20, 84 (1989).
22. B.T. Hawkins and R.D. Egleton, J. Neurosci. Method 151, 262 (2006).
23. H.Y. Chen, T.Y. Chen, M.Y. Lee, S.T. Chen, Y.S. Hsu, Y.L. Kuo, G.L. Chang, T.S. Wu, and E.J. Lee, J. Pineal. Res. 41, 175 (2006).
24. B.T. Hawkins and T.P. Davis, Pharmacol. Rev. 57, 173 (2005).